Improving continuity of clinical care and educating general practitioners – development and evaluation of information sheets about chemotherapy for general practitioners

Improving continuity of clinical care and educating general practitioners – development and evaluation of information sheets about chemotherapy in patients with cancer for general practitioners

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000215527

Acronym

GP Fax Sheets

Enrollment

100

Registered

2006-05-31

Start date

2006-05-24

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary objective of this project is to demonstrate that the provision of information about chemotherapy and management of chemotherapy side effects 1.is perceived by GPs to be useful and, 2.when compared to usual care, results in (a)improved knowledge; (b)enhanced confidence regarding the management of patients having chemotherapy and (c)higher satisfaction with shared care with Peter Mac

Interventions

The intervention involves standardised faxed information (letter and drug information sheets) being sent to the GP of patients receiving chemotherapy at Peter Maccallum Cancer Centre. The faxed sheet will be one page long and sent immediately after the establishment of a baseline (a questionnaire testing GPs knowledge of their patients chemotherapy regime related side-effects administered directly after a patient begins their chemotherapy regime).

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Educational / counselling / training

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

To be eligible GPs must:1.Be the nominated GP of a patient with a defined cancer type, who is scheduled to commence a defined chemotherapy regimen 2.Agree to be randomised to either the intervention group who will receive faxed or e-mailed information or to the usual contact group3.Agree to participate in two brief telephone surveys (‘pre’ and ‘post’)4.Provide verbal informed consent to participate in this study

Exclusion criteria

To be eligible GPs must not:1.have already been enrolled in this study (if the same GP is treating two patients who are receiving chemotherapy in the Day Ward at Peter MacCallum Cancer Centre only the 1st patient will be included in this study)2. have a patient is is receiving concurrent radiotherapy.All age ranges and both genders will be included within the study.

Outcome results